NM  protein was originally identifi ed as a metastasis suppressor protein. Th e expression of NM has been correlated with tumour metastatic potential in various human carcinoma, mostly in ductal breast and colorectal carcinomas. Evidence for their expression in gastric cancer is rather contradictory, both for protein expression status and prognostic value. Th is study was done to analyze the immunohistochemical expression of NM in gastric carcinoma, and correlation of the degree of staining with clinicopathological parameters was investigated. In a retrospective immunohistochemical study specimens obtained from  gastric cancer patients who had undergone gastrectomy with perigastric lymphadenectomy were analysed, in correlation with classical clinical-pathological parameters of tumours, WHO-, Lauren-, Goseki-, and Ming-classifi cation. NM  gene expression was compared in gastric adenocarcinoma and tumour-adjacent non-neoplastic gastric mucosa. A semiquantitative immunostaining evaluation (score -) was used, counting the percentage of stained cells. Statistical analysis was performed using Kolmogorov-Smirnov test, and Spearman rank correlation test. Th e investigated group consisted of  males and  females (.:) with a mean age of  years (range: - years). Th e percentage of positive expression of NM (score ) were in  (.) specimens in non-neoplastic mucosa in adjacent gastric carcinoma, and negative (score -) in all  () specimens of gastric adenocarcinoma. NM expression was higher in non-neoplastic mucosa than in adjacent gastric adenocarcinoma tissue (p<.). NM protein expression did not correlate with gender (p=.), tumour size (p=.), tumour grade (p=.), lymphovascular invasion (p=.), lymph node metastases (p=.), Lauren classifi cation (p=.), Goseki classifi cation (p=.) and Ming classifi cation (p=.). Our series did not show a signifi cant correlation between NM expression and analysed clinico-pathological variables, but these results suggest that protein NM may have a role in gastric carcinoma pathogenesis.
INTRODUCTION
Th e gastric cancer is one of the most common cancer in the Western countries, with a persistently rising incidence. It is the second in cancer-related mortallity next to lung cancer. Metastasis is the main cause of death in this group, leading to locoregional or distant recurrence in late-stage tumours. Th e most important prognostic factors is UICC TNM stage determined by the depth of invasion, the involvement of the perigastric lymph nodes, and distant metastasis. It is essential to predict the risk of recurrence in order to minimize adverse effects and maximize the therapeutic eff ect in the treatment of cancer patients. Th ere is a need for new prognostic and predictive factors other than the TNM stage, because the prognosis varies among patients of the same stage. Activation or inactivation of multiple genes is involved in the various steps of tumour progression. Th e molecular basis of the metastatic disease is not known. Th e development and progression of gastric cancer are results of multiple genetic alterations, like in many others cancers. Recently published studies revealed potential function of oncogenes and tumour suppressor genes, growth factors and receptors, cell adhesion molecules, proteolytic molecules and angiogenic factors, in the prognosis and prediction for gastric cancer [] . Several molecular factors are studied as prognostic and predictive factors for gastric cancer. Biological markers -p, PCNA, HER-, known to be indicators of prognosis in gastric cancer [] . The non metastatic NM gene was initially identified as a putative metastasis suppressor gene on the basis of its reduced expression in certain highly metastatic cell lines and tumours [] . The gene is located on chromosome locus q, which encodes an . kDa protein containing  amino acid residues with nucleoside diphosphate kinase, histidine kinase and serine autophosphorylation activities [] . In humans, there are  genes belonging to the NM gene family (also known as NME genes), of which the two most abundantly expressed are NM-H (NME) and NM-H (NME) [] . Th e NM genes appear to play a critical role in cellular proliferation, differentiation, oncogenesis, and tumour metastasis [] . A recent study delineated that NM-H is critical for control of cell-cell adhesion and cell migration at early stages of the invasive program in epithelial cancers, orchestrating a barrier against conversion of in situ carcinoma into invasive malignancy [] . Low NM-H expression disrupted cell-cell adhesion and promoted cellular scattering, motility, and extracellular matrix invasion by upregulating several matrix metalloproteinases [] . It is critical at early stages of the invasive cancers. Low NM-H expression was ineffective at tumour invasion [] . Up to now, it is clearly established that NM-H is a critical regulator of signalling networks involved in cancer cell adhesion and local invasion in primary tumours [] . Fan et al. suggested that NM-H may be associated in DNA repair [] . Mutation in NM genes are rare in cancer, and NM may be a family of cancer genes that become dysregulated through expression changes at protein level. Youssef et al. suggest that the role NM in oncogenesis and tumour metastasis could be related to its nucleoside diphosphate kinase activity [] . NM is clearly a multifunctional protein distributed in the cytosol and plasma membrane, as well as the nucleus. However, the mechanism by which NM suppresses tumour metastasis is still poorly understood. Detection of NM frequency expression in clinical specimens varied among different cancers, and no same results of prognostic analysis were achieved. It seems that the biological significance of NM gene expression depends on the type of neoplastic tissue [] . The expression of the putative metastasis-suppressor gene NM in gastric carcinoma is controversial [, ] . Th e objective of this study was to analyze NM expression and its association with clinical-pathological variables of tumour, and to analyze prognostic criteria for gastric adenocarcinoma determining loco-regional node metastatic potential.
MATERIALS AND METHODS

Patients
The biopsy specimens from  patients ( men, and  women) with invasive gastric adenocarcinoma diagnosed at the Department of Pathology, Faculty of Medicine University of Sarajevo, Bosnia and Herzegovina, from January  to December , were selected for this study. All clinicalpathological data are summarized according to the treatment arm in Table  . Gastric adenocarcinoma specimens were reviewed using morphologic and immunohistochemical criteria according to the WHO classifi cation of gastric carcinoma [] and staged according to TNM classifi cation [] . All of the samples were routinely fi xed in  buff ered formalin, embedded in paraffi n, and cut into  μm section. Four blocks from each tumour specimens were submitted for paraffi n embedding, each containing as mush as possible tumour tissue with the deep advancing edge and piece of adjacent mucosa. One block of them contains pieces of morphologically normal distant mucosa, at  cm from the tumour.
Immunohistochemical staining
Immunohistochemical analyses of the expressions of NM were performed according to the routine processes. Briefl y, -μm sections of tumour or normal tissues were mounted on poly-D-lysine coated slides. Th in sections were deparaffi nized in xylene and rehydrated in a series of ethanol solutions (, , and ) for  minutes each, washed in distilled water and . PBS (pH .), immersed in  mmol/L citrate buff er (pH .) and put in a microwave for  min at °C for antigen retrieval. Th en they were placed in methanol containing  HO for  min at °C to block endogenous peroxidase activity and incubated with rabbit serum for  min to block non-specifi c antibody binding sites. Th e primary antibody was applied at a working concentration and incubated for  hours at °C. Th e monoclonal antibody used is anti-human NM (:; DAKO, Denmark). Th is antibody has affi nity for both H and H components of the NM protein. Th e secondary antibody and the avidin-biotin complex (ABC) were applied to slides. Diaminobenzidine (DAB) was used as a chromogen and sections were counterstained with Mayer's hematoxylin. Negative controls were obtained by replacing the primary antibody by non-immunized rabbit or mouse serum.
Quantifi cation of immunostaining
Positive results were visible as yellow to brown cytoplasmic staining for the investigated antibody. Th e expression of the antigen was evaluated in a semiquantitative manner [] . Th e criteria used to assess NM expression were based on the number of stained cells, and scores were assigned as follows: a) score <, score =-, score = -, score = or more stained cells. Scores  to  was considered as negative (protein down-expression) and score  was considered as positive (protein over-expression). Th e sections were examined assessing the percentage of cells with positive reaction in  microscopic fi elds at  magnifi cation (X). Non- 
RESULTS
Characteristics of  patients with gastric cancer are shown in Table  Th e immunohistochemical expression of NM was strictly cytoplasmic. There was no nuclear staining. The intensity of staining was not considered while evaluating the expression. Positive and negative NM staining was identifi ed in non-neoplastic gastric mucosa. Normal gastric epithelial cells were homogeneously stained (> ) by monoclonal anti NM antibody. Th is was considered as an intrinsic control although we studied positive and negative control slides. NM expressions in the adjancent non-neoplastic gastric mucosas were highly variable. Positive NM stain (score ) ( Figure  .) was observed in  (.) and negative stained in  (.) cases of adjacent gastric mucosa ( Figure . ). No expression of NM protein in  () gastric adenocarcinoma ( Figure  -.) . Th e normal gastric mucosa had the higher expression of NM, than gastric adenocarcinoma (p=.). NM expression was evaluated with respect to patients clinicopathological data (Table ) . NM showed no significant differences regarding gender (p=.), tumour size (p=.), tumour grade (p=.), lymphovascular invasion (p=.), lymph node metastases (p=.), Lauren-(p=.), Goseki-(p=.) and Ming classification (p=.). No significant correlation was found between †Staining intensity: 0<10%, 1=10-25%, 2= 26-50%, 3=>51% of stained cells. Scores 0 to 2 was considered as negative, and score 3 was considered as positive. ** Kolmogorow-Smirnov one sample test for testing uniform distribution. NM expression and analysed clinicopathologic factors. Table  . summarized the data with statistical analyses.
DISCUSSION
Two highly homogenous genes, NM-H and NM-H, have been described, both located on the long arm of chromosome , coding for the . an  kD proteins respectively. NM protein is a metastasis suppressor protein, expressed in all cellular compartments. In vitro correlates of suppression include reduced invasion, motility and soft agar colonization, and induction of diff erentiation. NM expression has been widely studied in various cancers and with their relation to staging and prognosis. NM expressions are generally, but not uniformly associated with improved prognosis in various type of carcinomas. Expression of NM has been shown to be inversely correlated with the metastatic potential of several human cancers. Reduced expression of NM in breast, hepatoecellular and ovarian carcinoma correlates with increased metastatic potential [-] , but in oesophageal squamous cell, prostate and lung carcinoma, disease progression is associated with increased NM  gene expression [,,] . Th e relatively large number of studies analysed NM protein in colorectal carcinoma [] , but a small number of them analysed this protein in gastric carcinoma [, , ] .
In the present study expression of NM protein was observed in normal gastric mucosa in . of cases with strong diffuse cytoplasmic staining. We observed a similar percentage (.) of cases with negative staining in adjacent non-neoplastic mucosa. Th ere were some diff erences about expression of NM in non-neoplastic mucosae in adjacent gastric cancer between diff erent persons. When compared the specimens between the two groups, NM expression did not demonstate signifi cant correlation. Our results do not support fi ndings of Muta's study. Muta analyzed gene and protein expression of NM, using Northern blot and immunohistochemical techniques [] . He noted that expression of NM protein in tumour tissue was higher than those in the corresponding normal mucosae. Th is suggests a linkage of NM in the process of the gastric cancer progression. Our results suggest that biological signifi cance of NM expression may be quite diff erent in the same organ. Neoplastic gastric tissue showed negative expression of NM, suggests that absent staining in gastric adenocarcinoma was associated with disease progression, but these mechanism is not understood and remain to be determined conclusively. In our series, the analysis of NM expression revealed a higher tumour grade, higher incidence of metastatic lymph nodes, higher intestinal type of tumours according to Lauren classifi cation, higher Goseki type  tumours and higher nodular/diff use type of tumours (Ming classifi cation), and advanced pT categories in patients without protein expression, although this result did not reach statistical significance. Th is result suggested that loos of NM expression in gastric carcinoma tissue may had relation with development, progression, invasion and metastasis of neoplasm. This finding suggests a potential protective effect of this protein in tumour genesis. Th is study indicates a complex role of NM  in gastric cancer and may not solely function as tumour suppressor protein as commonly perceived. Our results do not support fi ndings of similar studies. Th ere were also some discrepancies amnog previous studies of the same tumours [, , , ] . Lee et al. analysed the relationship of p, nm, PCNA and HER- with clinicopathological parameters in gastric cancer and the survival results [] . He concluded that expression of NM and p was related with poor prognosis of gastric cancer. Monig et al. analysed clinical signifi cance of NM gene expression in gastric cancer [] . Th eir series did not show a correlation of protein expression in neoplastic gastric tissue in terms of lymph node and distant metastasis or prognosis in gastric cancer patients. Yeung [] suggested that NM may have a role in gastric carcinoma pathogenesis, but do not show a correlation with metastasis. Muller [] analysed NM expression and prognostic impact in  gastric carcinoma. Expression of NM was detected in . (n=) of all tumours and demonstrated positive correlation with the intestinal type of tumour, according to the Lauren classifi cation and advanced pT categories, and was also correlated with the presence lymphatic vessel invasion. No correlation is demonstrated between NM expression and lymph node involvement.
Results of this study showed that expression of the NM metastasis suppressor gene is correlated with aggressive tumour growth and poor prognosis but it is not an independent prognostic marker. Nakamura [] has found expression of NM in  out of  cases of gastric carcinoma. Th ey results suggest that expression of this protein is correlated to tumour progression and / or proliferation rather than the suppression of metastasis. Such a variation may be due to heterogeneity of primary tumour distribution, methods of investigation and scoring systems for pathological variables.
CONCLUSION
In conclusion, our data of NM expression did not show a significant correlation between analysed clinical-pathological variables, but these results suggest that protein NM may have a role in gastric carcinoma pathogenesis. It is possible that NM could play variable roles in different molecular events and contribute to distinct outcome. The detailed biological roles of this marker in gastric carcinogenesis require further investigation.
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